Celldex Therapeutics (CLDX) Amortization - Intangibles (2010 - 2018)
Celldex Therapeutics' (CLDX) quarterly Amortization - Intangibles came in at $224000.0 in Q1 2018, little changed year-on-year from $224000.0 in Q1 2017, and little changed quarter-over-quarter from $224000.0 in Q4 2017.
Celldex Therapeutics (CLDX) Amortization - Intangibles (2010 - 2018) Analysis & Trends
Celldex Therapeutics' Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $224000.0 for Q1 2018.
- On a quarterly basis, Amortization - Intangibles changed 0.0% year-over-year to $224000.0 in Q1 2018; TTM through Dec 2018 was $224000.0, a 75.0% decrease from a year earlier, with the FY2018 full-year figure at $224000.0, down 75.0% from the prior year.
- Amortization - Intangibles steadied at $224000.0 in Q1 2018 per CLDX's latest filing, from $224000.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $254000.0 in Q2 2014 and bottomed at $224000.0 in Q1 2017.
- The 5-year median for Amortization - Intangibles is $253000.0 (2014), against an average of $243882.4.
- Across the five-year window, Amortization - Intangibles changed 0.0% in 2014 and declined 11.81% in 2017, its largest moves.
- Year by year, Amortization - Intangibles stood at $253000.0 in 2014, then changed by 0.0% to $253000.0 in 2015, then decreased by 6.32% to $237000.0 in 2016, then declined by 5.49% to $224000.0 in 2017, then changed by 0.0% to $224000.0 in 2018.
- Per Business Quant, the three latest CLDX Amortization - Intangibles figures stand at $224000.0 (Q1 2018), $224000.0 (Q4 2017), and $224000.0 (Q3 2017).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 224,000.00 |
| Dec 31, 2017 | 224,000.00 |
| Sep 30, 2017 | 224,000.00 |
| Jun 30, 2017 | 224,000.00 |
| Mar 31, 2017 | 224,000.00 |
| Dec 31, 2016 | 237,000.00 |
| Sep 30, 2016 | 254,000.00 |
| Jun 30, 2016 | 254,000.00 |
| Mar 31, 2016 | 253,000.00 |
| Dec 31, 2015 | 253,000.00 |
| Sep 30, 2015 | 254,000.00 |
| Jun 30, 2015 | 254,000.00 |
| Mar 31, 2015 | 253,000.00 |
| Dec 31, 2014 | 253,000.00 |
| Sep 30, 2014 | 254,000.00 |
| Jun 30, 2014 | 254,000.00 |
| Mar 31, 2014 | 253,000.00 |
| Dec 31, 2013 | 253,000.00 |
| Sep 30, 2013 | 254,000.00 |
| Jun 30, 2013 | 254,000.00 |